Comparing electrical acupoint stimulation and TENS for lowering blood pressure in hypertension patients
Trans Cutaneous Electrical Acupoint Stimulation Versus TENS On Blood Pressure And Quality Of Life In Patients With Primary Hypertension
This study is testing whether a new type of electrical treatment or a standard nerve stimulation can help lower blood pressure and improve quality of life for people with high blood pressure.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 50 Years to 60 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza) |
| Trial ID | NCT06401278 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effects of transcutaneous electrical acupoint stimulation and transcutaneous electrical nerve stimulation (TENS) on blood pressure and quality of life in patients diagnosed with primary hypertension. It will involve 60 patients aged 50 to 60 years, with specific blood pressure and BMI criteria. The study will assess how these two interventions influence blood pressure levels and overall well-being over a defined period. Participants will be medically stable and will have been on consistent treatment for hypertension.
Who should consider this trial
Good fit: Ideal candidates are adults aged 50 to 60 with primary hypertension, stable medical conditions, and specific blood pressure and BMI ranges.
Not a fit: Patients with secondary hypertension or significant cardiac issues will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive treatment option for managing blood pressure in patients with hypertension.
How similar studies have performed: Previous studies have shown promising results with similar non-invasive approaches to managing hypertension, suggesting potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\) Sixty patients from both sexes diagnosed with essential HT at least 6 months ago. 2\) Their age will be ranged from 50 to 60 years old. 3) Their blood pressure will be ranged from (SBP is 140 -159 mmHg and/or DBP is 90-99 mmHg). 4\) Their body mass index (BMI) ranged from will be ranged from 24.9 to 29.9 kg/m2. 5\) All patients are medically stable and receive the same medical treatment 6) All patient nonsmoker or quitted smoking for at least 4-5 years 7) All patients will be similar in terms of status of functional activity, status of eating a salt-free diet and the presence of any chronic disease except HT Exclusion Criteria: * 1\) Secondary hypertension 2) Patients with cardiac problems e.g. atrial fibrillation, left bundle-branch block, heart failure, recent myocardial infarction, coronary artery disease, or participation in cardiac rehabilitation following bypass surgery. 3\) Patients with history, symptoms of, and/or laboratory reports suggestive of renal, neurologic, or hepatic complications. 4\) Use of a cardiac pacemaker 5) Any metal implants at site of application of TENS 6) Dermatological abnormalities at the site of the application of TENS 7) Obesity with body mass index (BMI) \> 30 kg/m2 8) Smoker, diabetes. 9) Soft tissue, nerve, and vascular diseases of upper or lower extremities which hinder the application of TEAS.
Where this trial is running
Giza
- Faculty of physical therapy- Cairo Uni. — Giza, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.